Schedule 13G ownership disclosure

IN8bio, Inc.

Common Stock, $0.0001 Par Value Per Share · CUSIP: 45674E208

Event date: 2025-06-30

Filing-level shares
107,416.00
Percent of class
2.6%
  • Transcend Partners Opportunity Fund LLC

    Shares: 107,416.00 · Class: 2.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-021669
Form type
SCHEDULE 13G/A
Filer
IN8BIO, INC.
CIK
CIK 1740279
Filed
Aug 13, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub